Fig. 2.

Fig. 2. Strategies for targeting the protease of SARS-CoV-2. (A) GRL0617. (B) Calpeptin. (C) Pelitinib. (D) Tideglusib. (E) AT7519 (F) Carmofur. (G) Tolperisone. (H) MUT056399. (I) Ebselen. (J) Triglycidyl isocyanurate. (K) Ifenprodil. (L) A schematic of the main protease of SARS-CoV-2. The active site and allosteric sites are highlighted.

© J. Microbiol. Biotechnol.